Spirovant Sciences is developing novel gene therapies for cystic fibrosis and other pulmonary diseases.

Biotechnology

Health Care

Life Sciences

Spirovant

Spirovant's headquarters in Pausa, Germany

Joan L.

Jessica (Ling) Lee

Eric Yuen

The Research and Development team at Spirovant Sciences is dedicated to advancing novel gene therapies for cystic fibrosis and other pulmonary diseases. By collaborating across various scientific disciplines, including upstream and downstream process development, analytical testing, and laboratory management, the team focuses on innovating and refining therapeutic solutions to improve patient outcomes and drive the progress of gene therapy initiatives.

Research and Development

The Leadership Team at Spirovant Sciences is responsible for shaping the strategic direction and overall vision of the company as it develops innovative gene therapies for cystic fibrosis and other pulmonary diseases. Comprising experts in development, technology, medicine, and research, the team collaborates to drive scientific advancements, oversee clinical progress, and foster partnerships that enhance the company’s mission of improving patient outcomes.

Leadership Team

The Research and Development team at Spirovant Sciences focuses on advancing innovative gene therapies aimed at treating cystic fibrosis and other pulmonary diseases. This multidisciplinary group, led by senior leadership, collaborates on preclinical and clinical research initiatives, ensuring the scientific rigor and strategic alignment of projects to optimize the development pipeline and bring groundbreaking treatments to patients.

Spirovant

Org chart

Teams

Research and Development

Leadership Team

Research and Development

Offices

Spirovant

Org chart

Teams

Research and Development

Leadership Team

Research and Development

Offices

Related companies